DK1411917T3 - Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser - Google Patents

Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser

Info

Publication number
DK1411917T3
DK1411917T3 DK02714978T DK02714978T DK1411917T3 DK 1411917 T3 DK1411917 T3 DK 1411917T3 DK 02714978 T DK02714978 T DK 02714978T DK 02714978 T DK02714978 T DK 02714978T DK 1411917 T3 DK1411917 T3 DK 1411917T3
Authority
DK
Denmark
Prior art keywords
prevention
treatment
movement disorders
carbamate compounds
carbamate
Prior art date
Application number
DK02714978T
Other languages
Danish (da)
English (en)
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1411917T3 publication Critical patent/DK1411917T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02714978T 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser DK1411917T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27168301P 2001-02-27 2001-02-27
US10/081,501 US6589985B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating movement disorders
PCT/US2002/005542 WO2002067926A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating movement disorders

Publications (1)

Publication Number Publication Date
DK1411917T3 true DK1411917T3 (da) 2007-09-24

Family

ID=26765643

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02714978T DK1411917T3 (da) 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser

Country Status (28)

Country Link
US (1) US6589985B2 (el)
EP (1) EP1411917B1 (el)
JP (1) JP2004527492A (el)
KR (1) KR100858232B1 (el)
CN (1) CN1262272C (el)
AR (1) AR033426A1 (el)
AT (1) ATE369130T1 (el)
AU (1) AU2002247204B2 (el)
BR (1) BR0207831A (el)
CA (1) CA2439478C (el)
CY (1) CY1106924T1 (el)
CZ (1) CZ20032299A3 (el)
DE (1) DE60221670T2 (el)
DK (1) DK1411917T3 (el)
ES (1) ES2291454T3 (el)
HK (1) HK1067305A1 (el)
HU (1) HUP0303344A3 (el)
IL (2) IL157592A0 (el)
MX (1) MXPA03007719A (el)
MY (1) MY157373A (el)
NO (1) NO20033803L (el)
NZ (1) NZ551954A (el)
PL (1) PL364679A1 (el)
PT (1) PT1411917E (el)
RS (1) RS50676B (el)
RU (1) RU2294739C2 (el)
TW (1) TWI331524B (el)
WO (1) WO2002067926A1 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200401511T4 (tr) * 2000-07-21 2004-08-23 Ortho-Mcneil Pharmaceutical, Inc. Nöropatik ağrı ve baş ağrısı nöbetleri ve migren tipi baş ağrısı ile ilişkili ağrının önlenmesi veya tedavi edilmesinde kullanılan karbamat bileşikleri.
MXPA03007718A (es) * 2001-02-27 2004-11-12 Johnson & Johnson Compuestos de carbamato para usarse en la prevencion o tratamiento de trastornos neurodegenerativos.
ES2327721T3 (es) 2001-07-16 2009-11-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Compuestos de carbamato para uso en la prevencion o tratamiento del dolor neuropatico.
US8440715B2 (en) 2005-06-08 2013-05-14 Sk Biopharmaceuticals Co., Ltd. Treatment of sleep-wake disorders
PE20070325A1 (es) * 2005-06-29 2007-05-12 Alza Corp Formas de dosificacion oral que comprenden compuestos derivados de carbamato
CA2616721C (en) * 2005-07-26 2014-01-21 Janssen Pharmaceutica N.V. Methods for treating substance-related disorders
EP2089011A1 (en) * 2006-10-31 2009-08-19 Janssen Pharmaceutica N.V. Treatment of pervasive developmental disorders
AU2010316106B2 (en) 2009-11-06 2015-10-22 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
CA2779442A1 (en) 2009-11-06 2011-05-12 Sk Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
US8623913B2 (en) * 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
WO2014142549A1 (en) 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
JP6062077B2 (ja) 2013-03-12 2017-01-18 バイオ−ファーム ソリューションズ カンパニー リミテッド 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes}
US10351519B2 (en) 2016-02-29 2019-07-16 Bio-Pharm Solutions Co., Ltd. Sulfamate derivative compounds, processes for preparing them and their uses
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
CA3046300A1 (en) 2016-12-14 2018-06-21 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome
WO2018222954A1 (en) 2017-06-02 2018-12-06 Jazz Pharmaceuticals International Iii Limited Methods and compositions for treating excessive sleepiness
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function
WO2022045824A1 (en) * 2020-08-31 2022-03-03 Bio-Pharm Solutions Co., Ltd. Phenyl alkyl carbamate compounds for use in preventing or treating neurodegenerative disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
MXPA03007719A (es) 2004-11-12
HK1067305A1 (en) 2005-04-08
DE60221670D1 (de) 2007-09-20
AU2002247204B2 (en) 2006-08-24
ATE369130T1 (de) 2007-08-15
AR033426A1 (es) 2003-12-17
HUP0303344A3 (en) 2012-07-30
ES2291454T3 (es) 2008-03-01
US20020151585A1 (en) 2002-10-17
WO2002067926A1 (en) 2002-09-06
MY157373A (en) 2016-06-15
EP1411917B1 (en) 2007-08-08
NO20033803D0 (no) 2003-08-26
JP2004527492A (ja) 2004-09-09
CA2439478C (en) 2010-05-18
NO20033803L (no) 2003-10-10
EP1411917A1 (en) 2004-04-28
KR20030074847A (ko) 2003-09-19
HUP0303344A2 (hu) 2004-01-28
RU2003128985A (ru) 2005-03-10
CN1505508A (zh) 2004-06-16
DE60221670T2 (de) 2008-04-30
IL157592A0 (en) 2004-03-28
PL364679A1 (en) 2004-12-13
CZ20032299A3 (cs) 2004-08-18
BR0207831A (pt) 2004-06-22
KR100858232B1 (ko) 2008-09-12
PT1411917E (pt) 2007-09-17
US6589985B2 (en) 2003-07-08
CY1106924T1 (el) 2012-09-26
RU2294739C2 (ru) 2007-03-10
YU67703A (sh) 2006-08-17
RS50676B (sr) 2010-06-30
TWI331524B (en) 2010-10-11
NZ551954A (en) 2008-07-31
CA2439478A1 (en) 2002-09-06
CN1262272C (zh) 2006-07-05
IL157592A (en) 2009-12-24

Similar Documents

Publication Publication Date Title
DK1411917T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser
DK1427437T3 (da) Oxyntomodulin til forebyggelse eller behandling af overvægt
DK1446122T5 (da) Anvendelse af flibanserin til behandling af uregelmæssigheder ved könsdriften
IS7099A (is) Efnasambönd til að meðhöndla bólgutruflanir
DK1425001T3 (da) Phenethanolaminderivater til behandling af respiratoriske sygdomme
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1420759T3 (da) Farmaceutiske sammensætninger til behandling af astma
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1383489T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neurodegeneative sygdomme
DK1450606T3 (da) Synergistiske sammensætninger til behandling af såsæd
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
DK1499730T3 (da) Immunokonjugater til behandling af tumorer
DK1491212T3 (da) Middel til behandling af søvnforstyrrelser
ITMI20031311A0 (it) Formulazioni per il trattamento di disturbi artrosici
DK1694342T3 (da) Fremgangsmåder til anvendelse af gelsolin til behandling eller forebyggelse af bakteriel sepsis
DK1344526T3 (da) Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser
NO20033804L (no) Karbamatforbindelser for behandling av smerte
DK1401424T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af psykotiske forstyrrelser
DK2845594T3 (da) Anvendelse af dihydroimidazoloner til behandlingen af hunde.
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1461042T3 (da) Anvendelse af desoxypeganin til behandling af klinisk depression
DK1390364T3 (da) Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression
DK1468686T3 (da) S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser
DK1157987T3 (da) S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser